Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Total Liabilities (Quarterly): 2.250B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.250B |
| March 31, 2024 | 2.221B |
| December 31, 2023 | 2.514B |
| September 30, 2023 | 2.336B |
| June 30, 2023 | 2.440B |
| March 31, 2023 | 2.438B |
| December 31, 2022 | 2.893B |
| September 30, 2022 | 2.833B |
| June 30, 2022 | 3.040B |
| March 31, 2022 | 2.770B |
| December 31, 2021 | 2.928B |
| September 30, 2021 | 2.105B |
| June 30, 2021 | 2.004B |
| March 31, 2021 | 1.569B |
| December 31, 2020 | 955.27M |
| September 30, 2020 | 837.58M |
| June 30, 2020 | 747.70M |
| March 31, 2020 | 352.04M |
| December 31, 2019 | 358.97M |
| September 30, 2019 | 354.65M |
| June 30, 2019 | 374.88M |
| March 31, 2019 | 371.90M |
| December 31, 2018 | 375.91M |
| September 30, 2018 | 377.16M |
| June 30, 2018 | 373.51M |
| Date | Value |
|---|---|
| March 31, 2018 | 375.44M |
| December 31, 2017 | 404.22M |
| September 30, 2017 | 408.23M |
| June 30, 2017 | 414.77M |
| March 31, 2017 | 390.60M |
| December 31, 2016 | 399.85M |
| September 30, 2016 | 409.84M |
| June 30, 2016 | 414.89M |
| March 31, 2016 | 407.07M |
| December 31, 2015 | 93.37M |
| September 30, 2015 | 37.62M |
| June 30, 2015 | 37.10M |
| March 31, 2015 | 39.14M |
| December 31, 2014 | 46.38M |
| September 30, 2014 | 30.86M |
| June 30, 2014 | 30.26M |
| March 31, 2014 | 27.54M |
| December 31, 2013 | 31.89M |
| September 30, 2013 | 28.50M |
| June 30, 2013 | 23.69M |
| March 31, 2013 | 21.14M |
| December 31, 2012 | 22.10M |
| September 30, 2012 | 19.17M |
| June 30, 2012 | 15.90M |
| March 31, 2012 | 14.31M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
352.04M
Minimum
Mar 2020
3.040B
Maximum
Jun 2022
1.979B
Average
2.250B
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 128.22B |
| Moderna Inc | 3.968B |
| BioCryst Pharmaceuticals Inc | 948.02M |
| Eli Lilly and Co | 61.29B |
| AIM ImmunoTech Inc | 9.613M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.819B |
| Shareholders Equity (Quarterly) | -431.71M |
| Debt to Equity Ratio | -0.3911 |
| Current Ratio | 1.039 |
| Net Debt Paydown Yield | -0.02% |